OLIFANT MEDICAL TEAM

The Olifant Medical team combines over 70 years of medical device design, development, medical care, and commercialization experience. Collectively, our team has brought over 15 medical devices to the market and has over 50 patents/applications. Our backgrounds include mechanical engineering, bioscience, quality system management, corporate finance, and clinical medicine.

Christopher Carroll, MS

Co-Founder 
& Chief Executive Officer

Combined 30+ years of academic and industry biomedical research experience. Last 11 years with roles in management & leading technical-scientific teams at a leading medical device company. Broad experience in device concept to commercialization.

Dr. Steven
Venticinque, MD

Co-Founder

& Chief Medical Officer

Professor of Anesthesiology and Surgery UT Health San Antonio. Over 25 Years of experience in Anesthesiology, Critical Care Medicine, & Military Field Medical Care. Skilled in 3D design and prototyping. Foundational author DOD JTTS Airway Management Guideline.

Justin Rice, MS

Co-Founder 
& Chief Technical Officer

Mechanical Engineering & Technology Management. 10 years of product development and device commercialization experience in disposables and devices. 8+ Class II medical device launches.

Jeffery Smith, MBA

Chief Operations Officer

FDA Quality system management.
12+ years of personnel and project management experience, manufacturing and supply chain oversight, customer service and marketing. Brought 7 medical device groups through FDA 510(k) approval. Increased revenue from
$12M to $50M annually.

Allison C. Komiyama,

Ph.D., R.A.C.

Regulatory Affairs

Lisa Mercer Owens

Public Relations & Marketing

Attorney

Gately & Morris, PC

Jeff Gately

BUSINESS ADVISORY BOARD

Jane Hart

Over 22 years of experience in the clinical research industry, including 5 years in medical devices.  Currently Vice President of Global Clinical Development at 3M Healthcare.  Jane started her career in Australia working in breast cancer research and relocated to the US 17 years ago.  Experienced with executing pre and post-market studies globally for both drugs and devices including FDA approval of a nanocoated cardiac stent, hormonal therapy for breast cancer and chemotherapy for hematological malignancies.

Faisal Khan

Director of Capital Formation of Biglari Capital Corp. Principal of Southwestern Money Management LLC, a Biglari Capital Subsidiary. He began his career by founding an investment management firm in 1997 that managed a mutual fund and subsequently consulted with national investment firms. Faisal is also Adjunct Professor of Finance at Trinity University having previously served as an Adjunct Professor of Finance at the University of Houston. He received his BS in Business and Finance from Trinity University and his MBA from Tulane University.

Dan Wadsworth

Over 30 years of experience leading innovation in scientific and engineering enterprises and driving value in public and private life science companies. Commercialized over 100 medical device technology advancements in fields including wound healing, cancer drug delivery, ESRD, atherosclerotic disease, and orthopedics. Dan has held executive leadership roles in medical device companies such as CR Bard (BD) and KCI (Acelity). Has led commercialization, R&D, quality and regulatory efforts. Co-founder and COO of Metric Medical Devices, Inc. Two US patents in chemotherapy drug delivery.

Gregg Topoleski

With over 20 years of experience in finance, Gregg has spent the past 11 years in the Med Tech space.  He started his career with General Electric working in various Industrial, MEMS/Sensing, and Security industries.  He then joined GE Healthcare with roles in Life Support Systems, Business Development, and Anesthesia & Respiratory, leading that division as the Global CFO.  Gregg went on to lead as VP of Finance, Global Operations & Innovation for privately held Acelity, until a successful exit/acquisition by 3M Healthcare. Currently he is leading Finance Pipeline & Strategy for Exact Sciences, a cancer diagnostic company.  He has deep domain knowledge & experience with Med Tech R&D, finance, and strategy.

Richard Petty 

Richard has a professional career spanning more than 30 years in business and academia. He has been professor or visiting academic and delivered lectures and keynote addresses at universities including Macquarie Graduate School of Management,The University of Hong Kong, Stanford Graduate School of Business, University of New South Wales, and Emory University. Richard has authored and/or co-authored more than 100 academic and professional works including several books, and received awards as a researcher, an editor of academic works, and as an educator. Richard’s work has been used to help inform policy formulation in several countries.

 

In business, Richard has founded several companies and is an active investor. He has since 1998 served on numerous public and private company boards. Richard is immediate past Chair of the Australian Chamber of Commerce Hong Kong & Macau(2012-2017) and a past Chair and President of CPA Australia (2009-2010). He is a Board Member of International Federation of Accountants (New York; since 2014) Richard was appointed to serve as a member of the Business20 (B20) alongside the G20 in 2016 and he presently serves on the B20 Financing Growth and Infrastructure Taskforce. He has also advised on significant projects and investments made in Asia both by the private sector and by various governments.

 

Richard holds several degrees, including a PhD, and is a university medalist. He is a Fellow of CPA Australia, a Fellow of Chartered Accountants Australia and New Zealand, and a Fellow of the Australian Institute of Company Directors. Richard has lived and worked in Asia for more than 20 years. 

Dr. Aaron Joffee, MD

Professor of Anesthesiology

University of Washington, Seattle

Dr. Christina Bird, MD

Associate Professor of Emergency Medicine. UT Health San Antonio

Dr. Andrew Muck, MD

Associate Professor of Emergency Medicine. UT Health San Antonio

TUSK Not Currently Available for Sale in the United States

All Rights Reserved 2020  |  Olifant Medical, Inc., San Antonio, TX

Info@olifantmedical.com

TUSK, OLIFANT MEDICAL and STAT ENCLOSURE are pending trademarks of Olifant Medical, Inc.

TUSK Tracheal Cannulator and/or its use may be covered by one or more of the following patents: PCT/US2019/032193, PCT/US2017/061967

Other U.S. patents pending. Other patents issued and/or pending outside of the U.S.

STAT ENCLOSURE patent pending.